DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20192418

A study for efficacy and safety of ferric carboxymaltose versus iron sucrose in iron deficiency anemia among pregnant women in tertiary care hospital

Divyani Agrawal, Deepa Lokwani Masand

Abstract


Background: Anemia is one of the common manageable problem among the pregnant women worldwide, which contributes to maternal and perinatal mortality. This study aims to compare the efficacy and safety of intravenous ferric carboxymaltose with intravenous iron sucrose in treating anemia during pregnancy. Objective of this study was to compare safety and efficacy of intravenous ferric carboxymaltose with intravenous ferric sucrose in iron deficiency anemia during pregnancy.

Methods: It’s an interventional prospective study conducted in Department of Obstetrics and Gynecology at NIMS, Jaipur, Rajasthan, India constituting of 100 pregnant women. Group 1- 50 pregnant women were treated with intravenous ferric carboxymaltose and Group 2: 50 pregnant women were treated with intravenous iron sucrose. Hemoglobin and serum ferritin levels were measured pre and post treatment with parenteral iron therapy. The efficacy of intravenous ferric carboxymaltose in comparison to intravenous iron sucrose was assessed. The evaluation of safety and tolerance with the parenteral therapy was also performed.

Results: Anemia during pregnancy was more prevalent among the reproductive age group and in multiparous women. The mean rise in the hemoglobin level with ferric carboxymaltose was 2.92 gm/dl and with that of iron, sucrose was 1.08 gm/dl. The man rise in the serum ferritin levels with ferric carboxymaltose was 64.97ng/ml and with iron sucrose was 31.64 ng/ml. Ferric carboxymaltose was observed to be safer with no adverse events in comparison to the Iron sucrose which was related with adverse events among 03 pregnant women.

Conclusions: Intravenous ferric carboxymaltose was more efficacious and safer in comparison to intravenous iron sucrose among pregnant women. Hence, ferric carboxymaltose is the drug of choice in treatment of iron deficiency anemia during pregnancy.


Keywords


Hemoglobin, Intravenous ferric carboxymaltose, Intravenous iron sucrose, Serum ferritin

Full Text:

PDF

References


World Health Organization. Micronutrient deficiencies: prevention and control guidelines. Geneva: World Health Organization, 2015. Available at; https://www.who.int/nutrition/publications/ WHO_WFP_UNICEFstatement.pdf. (Accessed on December 2018).

FOGSI General Clinical Practice Recommendations. Management of iron deficiency anaemia in pregnancy. 2016; Available at; (http://www.fogsi.org/wp-content/uploads/2016/ 05/The- evidence-base_IDA-Pregnancy-24-May-2016-Clean.pdf. (Accessed on December 2018).

Indian council of medical research evaluation of nutritional anaemia prophylaxis program task force study New Delhi; 1989. Available at; https://www.icmr.nic.in/sites/default/files/icmr_bulletins/bufeb00.pdf. (Accessed on December 2018).

Centre for disease control (CDC), criteria for anaemia in children and child bearing age women MMWR. 1989;38:400-4; Available at; https://www.cdc.gov/MMWR/preview/mmwrhtml/00051880.htm. (Accessed on November 2018).

FOGSI General Clinical Practice Recommendations. Management of Iron Deficiency Anemia in Pregnancy. Available at; www.fogsi.org/wp-content/uploads/2017/07/gcpr-recommendation-ida.pdf. (Accessed on January 2018).

Guidelines for Prevention of Maternal Anaemia. Available at; http://www.nrhmtn.gov.in/ guideline/RGPMA.pdf. (Accessed on December 2018).

Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. Intravenous iron treatment in pregnancy: comparison of highdose ferric carboxymaltose vs. iron sucrose. J Perinatal Med. 2012;40(5):469-74.

Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC pregnancy and Childbirth. 2014;14:115.

Friedrisch JR, Cancado RD. Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia. Braz J Hem Hemother. 2015;37(6):400-5.

Zeba D. Intravenous iron treatment in pregnancy: ferric carboxymaltose for correction of iron deficiency anaemia Faridpur. Med Coll J. 2017;12(2):54-7.

Singh S, Dhama V, Chaudhary R, Singh P. Comparing the safety and efficacy of intravenous iron sucrose and intravenous ferric carboxymaltose in treating postpartum anemia. Int J Reprod Contracept Obstet Gynecol. 2016;5:1451-6.

Joshi SD, Chikkagowdra S, Kumar VCM. Comparative study of efficacy and safety of intravenous ferric carboxy maltose versus iron sucrose in treatment of postpartum iron deficiency anemia. Int J Reprod Contracept Obstet Gynecol. 2016;5.

Anand T, Rahi M, Sharma P, Ingle GK. Issues in prevention of iron deficiency anemia in India. Nutrition. 2014;30(7-8):764-70.

Institute of Medicine, Committee on Nutritional Status During Pregnancy and Lactation. Washington DC: National Academy press. 1990;272:98.

Lone FW, Qureshi RN, Emanuel F. Maternal anaemia and its impact on perinatal outcome in a tertiary care hospital in Pakistan. Eastern Mediterr Health J. 2004;10:801-7.

VanWyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anaemia: a randomized controlled trial. Obstet Gynecol. 2007;110:267-78.

Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaccol Obstct. 2008;101:67-73.

Pavord S, Myers B, Robinson S, Allard S, Strong J. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156:588-600.

Crosby WH. The rationale for treating iron deficiency anaemia. Arch Int Med. 1984;144:471-2.

Bhandal N, Russel R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG. 2006;113(11):1248-52.

Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anaemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynaecol. 2002;186:518-22.

Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Arch Gynecol Obstet. 2010;282:577-80.

Garg R, Nigam A, Agrawa lP, Nigam A, Agrawa lR. Iron carboxymaltose: A safe and effective molecule to combat anaemia in pregnancy. Int J Cur Res Aca Rev. 2016;4(2):124-30.